Regenxbio (RGNX) Gross Profit (2014 - 2024)
Regenxbio (RGNX) posted Gross Profit of $14.9 million for Q4 2024, up 35.7% from $10.98 million a year earlier and up 26.1% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Gross Profit (2014 - 2024) Analysis & Trends
For FY2024, Regenxbio's Gross Profit came in at $49.76 million, down 6.2% from FY2023.
- Annual Gross Profit has declined for three consecutive years, though with a five-year compound annual growth rate of 13.0% (FY2019 to FY2024).
- In prior years, Regenxbio's Gross Profit was $53.03 million in FY2023 (-8.9%), $58.18 million in FY2022 (-86.1%), $418.51 million in FY2021 (+252.1%) and $118.85 million in FY2020 (+340.3%).
- The Q4 2024 figure stands as the highest quarterly Gross Profit since Q3 2023.
- On a year-over-year basis, Gross Profit increased in four of the last eight quarters, with growth averaging 7.6%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q3 2020, with growth of 568.1%; the weakest was Q4 2022, with a decline of 95.1%.
- According to Business Quant data, Gross Profit for the three prior quarters was $11.81 million (Q3 2024), $11.72 million (Q2 2024) and $11.34 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 14.90 Mn |
| Sep 30, 2024 | 11.81 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Mar 31, 2024 | 11.34 Mn |
| Dec 31, 2023 | 10.98 Mn |
| Sep 30, 2023 | 16.53 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 18.56 Mn |
| Sep 30, 2022 | 13.42 Mn |
| Jun 30, 2022 | 19.70 Mn |
| Mar 31, 2022 | 6.50 Mn |
| Dec 31, 2021 | 375.60 Mn |
| Sep 30, 2021 | 16.67 Mn |
| Jun 30, 2021 | 12.22 Mn |
| Mar 31, 2021 | 14.03 Mn |
| Dec 31, 2020 | 11.19 Mn |
| Sep 30, 2020 | 81.55 Mn |
| Jun 30, 2020 | 11.88 Mn |
| Mar 31, 2020 | 14.24 Mn |
API Access
Regenxbio Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();